Benzinga’s Top Pre-Market NASDAQ Losers (IMGN, OVTI, NOVL, ARMH)
ImmunoGen Inc (NASDAQ: IMGN) dipped 23.12% to $6.45 in the pre-market session. IMGN has received a Refuse to File (RTF) letter from the FDA for its breast cancer treatment.
OmniVision Technologies Inc (NASDAQ: OVTI) lost 2.85% to $21.50 in the pre-market session. OVTI had reported weaker-than-expected Q1 revenue.
Novell Inc (NASDAQ: NOVL) fell 2.30% to $5.51 in the pre-market session. NOVL had posted weaker-than-expected FQ3 results.
ARM Holdings Plc (NASDAQ: ARMH) slipped 0.91% to $15.29 in pre-market trading. ARMH’s earnings are likely to fall by 8.26% this year.
Read more from Benzinga's Company news.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
